
USA - NASDAQ:AKU - US01021X1000 - Common Stock
The current stock price of AKU is 0.2887 USD. In the past month the price increased by 88.69%. In the past year, price decreased by -83.87%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.53 | 100.19B | ||
| CI | THE CIGNA GROUP | 9.31 | 70.62B | ||
| LH | LABCORP HOLDINGS INC | 15.97 | 21.00B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.39 | 20.07B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.32 | 19.93B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.06B | ||
| HIMS | HIMS & HERS HEALTH INC | 71.98 | 9.27B | ||
| DVA | DAVITA INC | 13.4 | 8.84B | ||
| CHE | CHEMED CORP | 19.76 | 6.33B | ||
| RDNT | RADNET INC | 217.53 | 6.02B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.49 | 5.87B | ||
| OPCH | OPTION CARE HEALTH INC | 18.56 | 4.49B |
Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. The company is headquartered in Plantation, Florida and currently employs 3,859 full-time employees. The company went IPO on 2017-12-01. The firm provides imaging procedures, which include magnetic resonance imaging (MRI), computerized tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. The firm through a network of approximately 200 owned and/or operated imaging locations, outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across over 46 states. Its center locations include Delaware, Florida North, Florida Central, Florida South, Florida West, Illinois, Kansas, Massachusetts, Pennsylvania North, Pennsylvania South, Texas Dallas-Fort Worth, Texas El Paso, Texas North and Texas South. Its subsidiaries include Advanced Diagnostic Group, LLC, Advanced Diagnostic Resources, LLC and Affiliated PET Systems, LLC.
AKUMIN INC
8300 W Sunrise Blvd
Plantation FLORIDA US
Employees: 3859
Phone: 19546784489.0
Akumin, Inc. engages in the provision of outpatient diagnostic imaging services. The company is headquartered in Plantation, Florida and currently employs 3,859 full-time employees. The company went IPO on 2017-12-01. The firm provides imaging procedures, which include magnetic resonance imaging (MRI), computerized tomography (CT), positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other related procedures. Its cancer care services include a full suite of radiation therapy and related offerings. The firm through a network of approximately 200 owned and/or operated imaging locations, outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across over 46 states. Its center locations include Delaware, Florida North, Florida Central, Florida South, Florida West, Illinois, Kansas, Massachusetts, Pennsylvania North, Pennsylvania South, Texas Dallas-Fort Worth, Texas El Paso, Texas North and Texas South. Its subsidiaries include Advanced Diagnostic Group, LLC, Advanced Diagnostic Resources, LLC and Affiliated PET Systems, LLC.
The current stock price of AKU is 0.2887 USD. The price decreased by -17.87% in the last trading session.
AKU does not pay a dividend.
AKU has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
AKUMIN INC (AKU) operates in the Health Care sector and the Health Care Providers & Services industry.
AKUMIN INC (AKU) has a market capitalization of 25.84M USD. This makes AKU a Nano Cap stock.
You can find the ownership structure of AKUMIN INC (AKU) on the Ownership tab.
ChartMill assigns a technical rating of 5 / 10 to AKU. When comparing the yearly performance of all stocks, AKU is a bad performer in the overall market: 80.71% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to AKU. AKU has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AKU reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS decreased by -118.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.35% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed AKU and the average price target is 0.92 USD. This implies a price increase of 217.98% is expected in the next year compared to the current price of 0.2887.
For the next year, analysts expect an EPS growth of 45.08% and a revenue growth 3.13% for AKU